drugset / Trial / NCT03659201

Efficacy and Safety of Neosil on Chronic Effluvium

NCT03659201 ↗

Phase 4 Completed 232 enrolled EMS Luxbiotech · collab
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the efficacy of Neosil in the treatment of chronic effluvium

Timeline

Start
2018-09-03
Primary completion
2019-06-04
Completion
2020-03-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Neosil Unknown 2 unknown Oral
Subject Neosil complete Unknown 2 unknown Oral
Subject Pantogar Unknown 3 unknown Oral

Indications